162 related articles for article (PubMed ID: 2839578)
1. Characteristics of the immune response to poliovirus virion polypeptides after immunization with live or inactivated polio vaccines.
Zhaori G; Sun M; Ogra PL
J Infect Dis; 1988 Jul; 158(1):160-5. PubMed ID: 2839578
[TBL] [Abstract][Full Text] [Related]
2. Nasopharyngeal secretory antibody response to poliovirus type 3 virion proteins exhibit different specificities after immunization with live or inactivated poliovirus vaccines.
Zhaori G; Sun M; Faden HS; Ogra PL
J Infect Dis; 1989 Jun; 159(6):1018-24. PubMed ID: 2470831
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of immunization with live attenuated and inactivated poliovirus vaccines.
Ogra PL
Ann N Y Acad Sci; 1995 May; 754():97-107. PubMed ID: 7625685
[TBL] [Abstract][Full Text] [Related]
4. Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: systemic and local immune responses.
Faden H; Modlin JF; Thoms ML; McBean AM; Ferdon MB; Ogra PL
J Infect Dis; 1990 Dec; 162(6):1291-7. PubMed ID: 2172403
[TBL] [Abstract][Full Text] [Related]
5. Global eradication of poliomyelitis: reinvent the wheel or use existing options effectively?
Ogra PL
Public Health Rev; 1993-1994; 21(1-2):143-50. PubMed ID: 8041881
[TBL] [Abstract][Full Text] [Related]
6. Intestinal Immune Responses to Type 2 Oral Polio Vaccine (OPV) Challenge in Infants Previously Immunized With Bivalent OPV and Either High-Dose or Standard Inactivated Polio Vaccine.
Brickley EB; Strauch CB; Wieland-Alter WF; Connor RI; Lin S; Weiner JA; Ackerman ME; Arita M; Oberste MS; Weldon WC; Sáez-Llorens X; Bandyopadhyay AS; Wright PF
J Infect Dis; 2018 Jan; 217(3):371-380. PubMed ID: 29304199
[TBL] [Abstract][Full Text] [Related]
7. Mucosal immunity induced by enhance-potency inactivated and oral polio vaccines.
Onorato IM; Modlin JF; McBean AM; Thoms ML; Losonsky GA; Bernier RH
J Infect Dis; 1991 Jan; 163(1):1-6. PubMed ID: 1845806
[TBL] [Abstract][Full Text] [Related]
8. Neutralizing anti-polio antibody titre in newborn babies in post-polio eradication period in Nigeria.
Ughasoro MD; Nnakenyi I; Echendu N; Akpeh JO; Oji-Onuoha S; Anyaoha U; Mbanefo N; Ofodile K
Vaccine; 2023 Nov; 41(46):6820-6823. PubMed ID: 37806806
[TBL] [Abstract][Full Text] [Related]
9. Long-term evaluation of mucosal and systemic immunity and protection conferred by different polio booster vaccines.
Xiao Y; Daniell H
Vaccine; 2017 Sep; 35(40):5418-5425. PubMed ID: 28111147
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous administration of oral rhesus-human reassortant tetravalent (RRV-TV) rotavirus vaccine and oral poliovirus vaccine (OPV) in Thai infants.
Migasena S; Simasathien S; Samakoses R; Pitisuttitham P; Sangaroon P; van Steenis G; Beuvery EC; Bugg H; Bishop R; Davidson BL
Vaccine; 1995 Feb; 13(2):168-74. PubMed ID: 7625111
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of reactogenicity and immunogenicity of an oral and an inactivated polio vaccine.
Borcić B; Dobrovsak-Sourek V; Kaić B; Ljubicić M
Acta Med Croatica; 1998; 52(3):155-8. PubMed ID: 9818437
[TBL] [Abstract][Full Text] [Related]
12. Results of a clinical study of polio vaccine: the Buffalo experience.
Faden H
Pediatr Infect Dis J; 1991 Dec; 10(12):973-5. PubMed ID: 1766725
[TBL] [Abstract][Full Text] [Related]
13. Antibody responses to antigenic sites 1 and 3 of serotype 3 poliovirus after vaccination with oral live attenuated or inactivated poliovirus vaccine and after natural exposure.
Herremans T; Reimerink JH; Kimman TG; van Der Avoort HG; Koopmans MP
Clin Diagn Lab Immunol; 2000 Jan; 7(1):40-4. PubMed ID: 10618274
[TBL] [Abstract][Full Text] [Related]
14. Induction of mucosal immunity by inactivated poliovirus vaccine is dependent on previous mucosal contact with live virus.
Herremans TM; Reimerink JH; Buisman AM; Kimman TG; Koopmans MP
J Immunol; 1999 Apr; 162(8):5011-8. PubMed ID: 10202050
[TBL] [Abstract][Full Text] [Related]
15. Different secretory IgA antibody responses after immunization with inactivated and live poliovirus vaccines.
Hanson LA; Carlsson B; Jalil F; Lindblad BS; Khan SR; van Wezel AL
Rev Infect Dis; 1984; 6 Suppl 2():S356-60. PubMed ID: 6740073
[TBL] [Abstract][Full Text] [Related]
16. Induction of neutralizing antibodies by poliovirus capsid polypeptides VP1, VP2 and VP3.
van der Marel P; Hazendonk TG; Henneke MA; van Wezel AL
Vaccine; 1983 Dec; 1(1):17-22. PubMed ID: 6099638
[TBL] [Abstract][Full Text] [Related]
17. [Study of immunogenicity after primary vaccination by different sequential program of inactivated poliovirus vaccine and oral poliovirus vaccine].
Lu L; Li XM; Liu DL; Zhang HR; Zhang ZJ; Wang HH; Liu F; Ning ZQ; Zhang LW; Chu P; Xie YT; Xu Y; Li J; Pang XH; Deng Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2012 Jun; 46(6):510-3. PubMed ID: 22943896
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and reactogenicity of rhesus rotavirus vaccine given in combination with oral or inactivated poliovirus vaccines and diphtheria-tetanus-pertussis vaccine.
Jalil F; Zaman S; Carlsson B; Glass RI; Kapikian AZ; Mellander L; Hanson LA
Trans R Soc Trop Med Hyg; 1991; 85(2):292-6. PubMed ID: 1653474
[TBL] [Abstract][Full Text] [Related]
19. Mucosal immune response to poliovirus vaccines in childhood.
Ogra PL
Rev Infect Dis; 1984; 6 Suppl 2():S361-8. PubMed ID: 6740074
[TBL] [Abstract][Full Text] [Related]
20. Randomized, placebo-controlled trial of inactivated poliovirus vaccine in Cuba.
Cuba IPV Study Collaborative Group
N Engl J Med; 2007 Apr; 356(15):1536-44. PubMed ID: 17429085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
